flavoxate has been researched along with oxybutynin in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (37.50) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Anderson, GF; Fredericks, CM; Green, RL | 1 |
Hizukuri, M; Igarashi, M; Kubota, K; Matsuoka, Y; Murakami, F; Sunagane, N; Uruno, T; Wada, K; Yoshida, K | 1 |
Caine, M; Gin, S; Pietra, C; Ruffmann, R | 1 |
Levin, RM; Malkowicz, SB; Ruggieri, MR; Wein, AJ | 1 |
Hisayama, T; Iwase, M; Nagai, H; Sakuma, N; Takayanagi, I | 1 |
Abe, M; Ikeda, S; Ono, Y; Ujiie, A; Yamazaki, Y | 1 |
Kasama, T; Mayuzumi, K; Tamaru, K; Watanabe, K | 1 |
Applebaum, SM | 1 |
Chancellor, MB; Figueroa, TE; Kumon, H; Rivas, DA; Shenot, PJ; Watanabe, T | 1 |
Hamada, K; Kimura, K; Kimura, Y; Sasaki, Y; Seto, T; Ukai, Y; Yamazaki, C; Yoshikuni, Y | 1 |
Egberts, AC; Lenderink, AW; Leufkens, HG; Movig, KL | 1 |
Mohanty, NK; Paul, P; Sehgal, R | 1 |
Artibani, W; Asimakopoulos, AD; Carone, R; Cerruto, MA; Del Popolo, G; Finazzi-Agrò, E; La Martina, M | 1 |
3 review(s) available for flavoxate and oxybutynin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic agents in micturitional disorders.
Topics: Baclofen; Bethanechol Compounds; Dantrolene; Dicyclomine; Ephedrine; Flavoxate; Guanethidine; Humans; Imipramine; Mandelic Acids; Methyldopa; Neostigmine; Phenoxybenzamine; Phentolamine; Phenylephrine; Phenylpropanolamine; Propantheline; Propranolol; Quaternary Ammonium Compounds; Urinary Bladder; Urination Disorders | 1980 |
An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.
Topics: Benzilates; Drug Administration Schedule; Female; Flavoxate; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Patient Safety; Placebos; Quality of Life; Treatment Outcome; Urinary Bladder, Overactive | 2012 |
1 trial(s) available for flavoxate and oxybutynin
Article | Year |
---|---|
Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Enuresis; Female; Flavoxate; Humans; Imipramine; Male; Mandelic Acids; Parasympatholytics; Treatment Outcome; Ultrasonography; Urinary Bladder; Urodynamics | 2007 |
12 other study(ies) available for flavoxate and oxybutynin
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor.
Topics: Anesthetics, Local; Animals; Barium; Carbachol; Cyclohexanes; Flavonoids; Flavoxate; Humans; Imipramine; In Vitro Techniques; Male; Mandelic Acids; Rabbits; Urinary Bladder; Urodynamics | 1978 |
[Effects of tiropramide hydrochloride on the isolated detrusor and intravesical pressure of the bladder in situ in rats].
Topics: Animals; Butylamines; Dose-Response Relationship, Drug; Flavoxate; In Vitro Techniques; Male; Mandelic Acids; Manometry; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Rats; Rats, Wistar; Reflex; Tyrosine; Urinary Bladder; Urination | 1992 |
Antispasmodic effects of flavoxate, MFCA, and REC 15/2053 on smooth muscle of human prostate and urinary bladder.
Topics: Adenoma; Dose-Response Relationship, Drug; Flavoxate; Humans; Male; Mandelic Acids; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Prostate; Prostatic Neoplasms; Urinary Bladder | 1991 |
Comparison of calcium antagonist properties of antispasmotic agents.
Topics: Animals; Calcium; Calcium Channel Blockers; Flavoxate; Imipramine; Ion Channels; Male; Mandelic Acids; Parasympatholytics; Rabbits; Urinary Bladder; Urinary Bladder, Neurogenic | 1987 |
Pharmacological properties of tiropramide, an antispasmodic drug.
Topics: Animals; Calcium; Cecum; Female; Flavoxate; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Male; Mandelic Acids; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Parasympatholytics; Rabbits; Rats; Rats, Inbred Strains; Stomach; Trachea; Tyrosine; Urinary Bladder; Uterus | 1989 |
[Effect of terodiline hydrochloride in isolated rabbit detrusor].
Topics: Animals; Butylamines; Calcium Channel Blockers; Depression, Chemical; Dose-Response Relationship, Drug; Flavoxate; Guinea Pigs; In Vitro Techniques; Male; Mandelic Acids; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Rabbits; Urinary Bladder | 1987 |
[Effects of oxybutynin hydrochloride on the urinary bladder and urethra in in situ preparations].
Topics: Animals; Atropine; Cats; Drug Interactions; Female; Flavoxate; Hypogastric Plexus; Male; Mandelic Acids; Papaverine; Pelvis; Peripheral Nerves; Propantheline; Rabbits; Urethra; Urinary Bladder | 1986 |
In-vivo whole bladder response to anticholinergic and musculotropic agents in spinal cord injured rats.
Topics: Animals; Cholinergic Antagonists; Dose-Response Relationship, Drug; Flavoxate; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Propantheline; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urodynamics | 1997 |
Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency.
Topics: Animals; Atropine; Benzilates; Calcium Channel Blockers; Denervation; Disease Models, Animal; Flavoxate; Hypogastric Plexus; Male; Mandelic Acids; Parasympatholytics; Phenylacetates; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Incontinence | 1997 |
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinergic Antagonists; Drug Prescriptions; Drug Utilization; Flavoxate; Humans; Mandelic Acids; Mental Disorders; Middle Aged; Nervous System Diseases; Netherlands; Parasympatholytics; Pharmacies; Retrospective Studies; Risk Factors; Urination Disorders | 2001 |